(Press-News.org) Rochester, Minn. -- A new study by radiation oncologists at Mayo Clinic comparing the world's literature on outcomes of proton beam therapy in the treatment of a variety of advanced head and neck cancers of the skull base compared to intensity modulated radiation therapy (IMRT) has found that proton beam therapy significantly improved disease free survival and tumor control when compared to IMRT. The results appear in the journal Lancet Oncology.
"We undertook a systematic review and meta-analysis to compare the clinical outcomes of patients treated with proton therapy with patients receiving photon IMRT," says senior author Robert Foote, M.D., a radiation oncologist at Mayo Clinic. "Our findings suggest that the theoretical advantages of proton beam therapy may in fact be real."
Researchers reviewed studies of nasal cavity and paranasal sinus tumors through extensive database searches. They included studies of patients who had no previous treatment – neither primary radiation therapy nor adjuvant radiation therapy -- and patients who had recurrent disease. Researchers collected data on overall survival, disease-free survival, and tumor control, at five years and at the patient's longest follow-up. They used random-effect models to pool outcomes across studies and compared event rates of combined outcomes for proton therapy and IMRT using an interaction test.
Researchers found disease free survival to be significantly higher at five years for patients receiving proton therapy than for patients receiving IMRT (72% versus 50%). Tumor control did not differ between treatment groups at five years however tumor control was higher for patients receiving proton therapy than for IMRT at the longest follow-up (81% versus 64%).
INFORMATION:
Co-authors include Samir Patel, M.D., Zhen Wang, Ph.D., William Wong, M.D., Mohammad Hassan Murad, M.D., Courtney Buckey, Ph.D., Khaled Mohammed, M.B., B.Ch, Fares Alahdab, M.D., Mohammed Nabhan, M.D., and Steven Schild, M.D., all of Mayo Clinic.
The study was funded by the Mayo Foundation for Medical Education and Research.
About Mayo Clinic Cancer Center
As a leading institution funded by the National Cancer Institute, Mayo Clinic Cancer Center conducts basic, clinical and population science research, translating discoveries into improved methods for prevention, diagnosis, prognosis and therapy. For information on cancer clinical trials, call 1-855-776-0015 toll free.
About Mayo Clinic
Recognizing 150 years of serving humanity in 2014, Mayo Clinic is a nonprofit worldwide leader in medical care, research and education for people from all walks of life. For more information, visit 150 years.mayoclinic.org, http://www.mayoclinic.org/ and newsnetwork.mayoclinic.org.
MEDIA CONTACT:
Joe Dangor, Mayo Clinic Public Affairs, 507-284-5005, newsbureau@mayo.edu
Mayo Clinic: Proton therapy has advantages over IMRT for advanced head and neck cancers
2014-07-01
ELSE PRESS RELEASES FROM THIS DATE:
Video games could provide venue for exploring sustainability concepts
2014-07-01
CORVALLIS, Ore. – Could playing video games help people understand and address global sustainability issues such as pollution, drought or climate change? At least two researchers believe so, outlining their argument in a concept paper published in the journal First Monday.
Video games have the potential to educate the public and encourage development of creative solutions to social, economic and environmental problems, said Oregon State University's Shawna Kelly, one of the two authors of the article.
"Video games encourage creative and strategic thinking, which could ...
Studies: Addiction starts with an overcorrection in the brain
2014-07-01
The National Institutes of Health has turned to neuroscientists at the nation's most "Stone Cold Sober" university for help finding ways to treat drug and alcohol addiction.
Brigham Young University professor Scott Steffensen and his collaborators have published three new scientific papers that detail the brain mechanisms involved with addictive substances. And the NIH thinks Steffensen's on the right track, as evidenced by a $2-million grant that will help fund projects in his BYU lab for the next five years.
"Addiction is a brain disease that could be treated like ...
New bridge design improves earthquake resistance, reduces damage and speeds construction
2014-07-01
SEATTLE, Wash. - Researchers have developed a new design for the framework of columns and beams that support bridges, called "bents," to improve performance for better resistance to earthquakes, less damage and faster on-site construction.
The faster construction is achieved by pre-fabricating the columns and beams off-site and shipping them to the site, where they are erected and connected quickly.
"The design of reinforced concrete bridges in seismic regions has changed little since the mid-1970s," said John Stanton, a professor in the Department of Civil and Environmental ...
Chinese herbal extract may help kill off pancreatic cancer cells
2014-07-01
Bethesda, Md. (July 1, 2014) — A diagnosis of pancreatic cancer—the fourth most common cause of cancer death in the U.S.—can be devastating. Due in part to aggressive cell replication and tumor growth, pancreatic cancer progresses quickly and has a low five-year survival rate (less than 5 percent).
GRP78, a protein that protects cells from dying, is more abundant in cancer cells and tissue than in normal organs and is thought to play a role in helping pancreatic cancer cells survive and thrive. Researchers at the University of Minnesota have found triptolide, an extract ...
Tags reveal Chilean devil rays are among ocean's deepest divers
2014-07-01
Thought to dwell mostly near the ocean's surface, Chilean devil rays (Mobula tarapacana) are most often seen gliding through shallow, warm waters. But a new study by scientists at Woods Hole Oceanographic Institution (WHOI) and international colleagues reveals that these large and majestic creatures are actually among the deepest-diving ocean animals.
"So little is known about these rays," said Simon Thorrold, a biologist at WHOI and one of the authors of the paper, published July 1, 2014, in the journal Nature Communications. "We thought they probably travelled long ...
Bringing the bling to antibacterials
2014-07-01
WASHINGTON D.C., July 1, 2014 – Bacteria love to colonize surfaces inside your body, but they have a hard time getting past your rugged, salty skin. Surgeries to implant medical devices often give such bacteria the opportunity needed to gain entry into the body cavity, allowing the implants themselves to act then as an ideal growing surface for biofilms.
A group of researchers at the Shanghai Institute of Ceramics in the Chinese Academy of Sciences are looking to combat these dangerous sub-dermal infections by upgrading your new hip or kneecap in a fashion appreciated ...
Efforts to cut unnecessary blood testing bring major decreases in health care spending
2014-07-01
Researchers at Johns Hopkins Bayview Medical Center used two relatively simple tactics to significantly reduce the number of unnecessary blood tests to assess symptoms of heart attack and chest pain and to achieve a large decrease in patient charges.
The team provided information and education to physicians about proven testing guidelines and made changes to the computerized provider order entry system at the medical center, part of the Johns Hopkins Health System. The guidelines call for more limited use of blood tests for so-called cardiac biomarkers. A year after implementation, ...
Separating finely mixed oil and water
2014-07-01
CAMBRIDGE, Mass-- Whenever there is a major spill of oil into water, the two tend to mix into a suspension of tiny droplets, called an emulsion, that is extremely hard to separate — and that can cause severe damage to ecosystems. But MIT researchers have discovered a new, inexpensive way of getting the two fluids apart again.
Their newly developed membrane could be manufactured at industrial scale, and could process large quantities of the finely mixed materials back into pure oil and water. The process is described in the journal Scientific Reports by MIT professor Kripa ...
Mayo Clinic researchers reveal treasure trove of genes key to kidney cancer
2014-07-01
JACKSONVILLE, Fla. — A genomic analysis of clear cell renal cell carcinoma (ccRCC), the most common form of kidney cancer, from 72 patients has uncovered 31 genes that are key to development, growth and spread of the cancer, say researchers from Mayo Clinic in Florida. Eight of these genes had not been previously linked to kidney cancer, and six other genes were never known to be involved in any form of cancer.
MULTIMEDIA ALERT: Video and audio are available for download on the Mayo Clinic News Network.
Their study, in the journal Oncotarget, is the most extensive analysis ...
Alcohol use disorders linked to decreased 'work trajectory'
2014-07-01
July 1, 2014 - John D. Meyer, MD, MPH, of Icahn-Mount Sinai School of Medicine, New York, and Miriam Mutambudzi, PhD, MPH, of Johns Hopkins School of Medicine, Baltimore, studied the relationship between occupation and AUDs in workers followed up from early adulthood to middle age. The study focused on the "substantive complexity" of work as an indicator of work trajectory—whether individuals were progressing in their careers in terms of factors such as decision latitude and expanded work abilities.
Based on factors such as drinking more than intended or unsuccessful ...